Evidence map›Paper›PMID 42278358›Full record

ArticleInternational journal of molecular sciences2026

Decellularized Testicular Extracellular Matrix Scaffolds Support Mature Spermatogenesis: Impact of Donor Age and Transplantation Microenvironment.

Jung-Hsiu Hou, How Tseng, Bo-Sheng Xiao, Yu-Chio Wang, Sung-Ming Weng, Chi-Huang Chen

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jung-Hsiu HouDivision of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei 110301, Taiwan.
How TsengGraduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Bo-Sheng XiaoDepartment of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0009-0006-0357-5135
Yu-Chio WangDivision of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei 110301, Taiwan.
Sung-Ming WengDepartment of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0009-0005-8064-8572
Chi-Huang ChenDivision of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei 110301, Taiwan.ORCID 0000-0002-4483-1645

Funding

National Science and Technology Council 112-2314-B-038-062National Science and Technology Council 113-2314-B-038-114National Science and Technology Council 114-2314-B-038-030
6 · The paper itself

Abstract

Immature testicular tissue transplantation is a promising strategy for restoring fertility in prepubertal boys undergoing gonadotoxic treatments, yet it faces challenges such as significant germ cell loss and poor graft survival due to the initial period without a blood supply. This study utilized an in vivo tissue-engineering platform involving decellularized testicular extracellular matrix to enhance graft stability and maturation. Immature testicular tissue from three-week-old transgenic mice was transplanted into age-matched recipient mice across four experimental groups: tissue co-transplanted with young decellularized matrix into a cleared testicular cavity, tissue with adult matrix in a cleared cavity, tissue transplanted alone in a cleared cavity, and tissue injected directly into an intact recipient testis. Graft growth was monitored longitudinally using bioluminescence imaging, and spermatogenesis was evaluated via histology and immunohistochemistry sixty-five days post-transplantation. The decellularization protocol successfully removed more than 98 percent of host deoxyribonucleic acid while preserving key matrix components. Grafts injected into intact testes showed the earliest bioluminescence peak but subsequently declined. Conversely, tissue co-transplanted with young decellularized matrix in a cleared cavity exhibited a delayed but significantly higher and more sustained peak compared to the group without a scaffold. The young matrix group appeared to provide more sustained support for spermatogenic progression, as reflected by a more stable increase and a prolonged spermatogenic peak over time. Evidence of advanced spermatogenic stages, including spermatids and sperm-like cells, was observed in all groups by day sixty-five. In conclusion, decellularized testicular matrix serves as a supportive bioactive scaffold that improves long-term graft stability, with outcomes significantly influenced by the age of the scaffold's donor and the transplantation microenvironment.

Indexed as

Decellularized Extracellular MatrixExtracellular MatrixSpermatogenesisTestisTissue ScaffoldsAnimalsMaleMiceMice, TransgenicTissue DonorsTissue EngineeringDecellularized Extracellular Matrixbioluminescence imagingdecellularized testicular extracellular matrixfertility preservationimmature testicular tissue transplantationmicroenvironmentregenerative medicinespermatogenesistesticular scaffoldtissue engineering

Identifiers

PMID42278358
PMCPMC13257167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.